Mike Lewis

Chief Revenue Officer

Mike Lewis is Chief Revenue Officer with Medrio. Before joining Medrio in January 2020, his more than 20-year executive sales career brought him worldwide. With companies like the CRO Navitas, IBM, and other life science industries, he had a solid history of transforming businesses, pinpointing the root cause of underperformance and turning it around while coaching, mentoring, and training a superior sales staff.  Along with a sophisticated understanding of cutting-edge technology, he had the ability to establish solid and trusted relationships with executives and clients alike. 

Mike earned a BA in political science with a minor in communist comparative studies from Union College in Schenectady, NY.

With Medrio, Mike is busy transforming our sales team to ensure that our customers and prospects have the best buying experience possible. Clinical trials are expensive and complex. Mike and his team work closely with our sponsors and CROs to ensure that they are in the best position to meet the requirements both from a regulatory perspective and patient safety.  Mike doesn’t believe that we are selling anything to anybody. He believes in working hard to create an atmosphere that lets our customers make the absolute best decision for their particular needs.

More Fun Facts About Mike

He has a rich life outside of work, which Medrio encourages. When he’s not maintaining his 280-year-old home in Bucks County, PA, he’s working out on his Peloton, hiking along the Delaware River, or reading the latest biography. He’s also a movie buff (and has two sons in LA who work in the industry), a rabid football fan (the World Cup European kind of football). He dreams of traveling again (another passion) while watching his favorite team, Manchester City, from home. 

Favorite Quote: “I prefer to be true to myself, even at the hazard of incurring the ridicule of others, rather than to be false, and to incur my own abhorrence.”
— Frederick Douglass

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.